Functional characterization of 21 CYP3A4 variants on amiodarone metabolism in vitro

被引:15
|
作者
Yang, Cheng-Cheng [1 ]
Zheng, Xiang [1 ]
Liu, Teng-Hui [1 ]
Wang, Chen-Chen [1 ]
Tang, Peng-Fei [1 ]
Chen, Zhe [1 ]
Zhang, Bo-Wen [1 ]
Fang, Ping [1 ]
Hu, Guo-Xin [1 ]
Cai, Jian-Ping [2 ,3 ]
机构
[1] Wenzhou Med Univ, Sch Pharm, Wenzhou 325035, Zhejiang, Peoples R China
[2] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China
[3] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China
关键词
Allelic variant; amiodarone; CYP3A4; polymorphisms; desethylamiodarone; drug metabolism; GENETIC POLYMORPHISMS; N-DEETHYLATION; IDENTIFICATION; PHARMACOKINETICS; VARIABILITY;
D O I
10.1080/00498254.2017.1414971
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1.Cytochrome P450 3A4 (CYP3A4) is an important member of the cytochrome P450 enzyme superfamily, with 33 allelic variants reported previously. Genetic polymorphisms of CYP3A4 can produce a significant effect on the efficacy and safety of some drugs, so the purpose of this study was to clarify the catalytic characteristics of 22 CYP3A4 allelic isoforms, including 6 novel variants in Han Chinese population, on the oxidative metabolism of amiodarone in vitro. 2.Wild-type CYP3A4*1 and other variants expressed by insect cells system were incubated respectively with 10-500 mu M substrate for 40 min at 37 degrees C and terminated at -80 degrees C immediately. Then these samples were treated as required and detected with ultra-performance liquid chromatography-tandem mass spectrometry used to analyze its major metabolite desethylamiodarone. 3.Among the 21 CYP3A4 variants, compared with the wild-type, the intrinsic clearance values (V-max/K-m) of two variants were apparently decreased (11.07 and 2.67% relative clearance) while twelve variants revealed markedly increased values (155.20 similar to 435.96%), and the remaining of seven variants exhibited no significant changes in enzyme activity. 4.This is the first time report describing all these infrequent alleles for amiodarone metabolism, which can provide fundamental data for further clinical studies on CYP3A4 alleles.
引用
收藏
页码:120 / 126
页数:7
相关论文
共 50 条
  • [21] Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro
    Xie, Sai-li
    Zhu, Xiayan
    Gao, Nanyong
    Lin, Qianmeng
    Chen, Chaojie
    Yang, Yun-jun
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    FOOD AND CHEMICAL TOXICOLOGY, 2023, 181
  • [22] In vitro metabolism of piperaquine is primarily mediated by CYP3A4
    Lee, Tina Ming-Na
    Huang, Liusheng
    Johnson, Marla K.
    Lizak, Patricia
    Kroetz, Deanna
    Aweeka, Francesca
    Parikh, Sunil
    XENOBIOTICA, 2012, 42 (11) : 1088 - 1095
  • [23] Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin in vitro
    Hu, Yingying
    Ye, Zhize
    Wu, Hualu
    Chen, Xiaohai
    Xia, Hailun
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 399
  • [24] The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells
    Zahno, Anja
    Brecht, Karin
    Morand, Rejane
    Maseneni, Swarna
    Toeroek, Michael
    Lindinger, Peter W.
    Kraehenbuehl, Stephan
    BIOCHEMICAL PHARMACOLOGY, 2011, 81 (03) : 432 - 441
  • [25] Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity
    Mikus, Gerd
    Foerster, Kathrin Isabelle
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1592 - S1599
  • [26] The Relative Contributions of CYP3A4 and CYP3A5 to the Metabolism of Vinorelbine
    Topletz, Ariel R.
    Dennison, Jennifer B.
    Barbuch, Robert J.
    Hadden, Chad E.
    Hall, Stephen D.
    Renbarger, Jamie L.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (09) : 1651 - 1661
  • [27] Genetic Variants of CYP3A4 and CYP3A5 in Cynomolgus and Rhesus Macaques
    Uno, Yasuhiro
    Matsushita, Akinori
    Osada, Naoki
    Uehara, Shotaro
    Kohara, Sakae
    Nagata, Ryoichi
    Fukuzaki, Koichiro
    Utoh, Masahiro
    Murayama, Norie
    Yamazaki, Hiroshi
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (02) : 209 - 214
  • [28] Functional Characterization of 40 CYP3A4 Variants by Assessing Midazolam 1′-Hydroxylation and Testosterone 6β-Hydroxylation
    Kumondai, Masaki
    Rico, Evelyn Marie Gutierrez
    Hishinuma, Eiji
    Ueda, Akiko
    Saito, Sakae
    Saigusa, Daisuke
    Tadaka, Shu
    Kinoshita, Kengo
    Nakayoshi, Tomoki
    Oda, Akifumi
    Abe, Ai
    Maekawa, Masamitsu
    Mano, Nariyasu
    Hirasawa, Noriyasu
    Hiratsuka, Masahiro
    DRUG METABOLISM AND DISPOSITION, 2021, 49 (03) : 212 - 220
  • [29] CYP3A4 drug metabolism considerations in pediatric pharmacotherapy
    Vander Schaaf, Marin
    Luth, Kyrle
    Townsend, Danyelle M.
    Chessman, Katherine H.
    Mills, Catherine M.
    Garner, Sandra S.
    Peterson, Yuri K.
    MEDICINAL CHEMISTRY RESEARCH, 2024, 33 (12) : 2221 - 2235
  • [30] Flavonoids as CYP3A4 Inhibitors In Vitro
    Kondza, Martin
    Brizic, Ivica
    Jokic, Stela
    BIOMEDICINES, 2024, 12 (03)